Google
VIVS — VIVOSIM LABS, INC. (Healthcare >> Biotechnology)
VIVS FAQ
What is VIVS's P/E ratio?
VIVOSIM LABS, INC. (VIVS) currently trades at a P/E ratio of 0.53.
What is VIVS's ROE?
VIVOSIM LABS, INC. reports a Return on Equity (ROE) of -27.63%.
What is VIVS's dividend yield?
VIVOSIM LABS, INC. offers a dividend yield of 0.00%.
What is VIVS's Deepscope Quality Score?
Deepscope rates VIVS's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VIVS?
Deepscope's AI Timing Score for VIVS is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VIVS belong to?
VIVOSIM LABS, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.20
Price
-0.15
(-11.11%)
Day Change
|
|
|---|
VIVS, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.20 |
| PBV / Sector |
0.82 / 4.63
GREAT
|
| Earning Per Share | -0.40 |
| PE / Sector |
0.53 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
-0.03 / 0.53
|
| Average 1M Daily Value |
0.07 M
GREAT
|
| Average 1W Daily Value |
0.11 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:31 |
| Symbol | VIVS |
| Name | VIVOSIM LABS, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 2.89 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 3.65 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 11555 Sorrento Valley Road, San Diego, CA, United States, 92121
Phone: 858 224 1000
Website: https://vivosim.ai
Sector: Healthcare >> Biotechnology
Description: VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
